BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33357196)

  • 1. Clinical Relevance and Immunohistochemical Patterns of Silent Pituitary Adenomas: 10 Years of Single-centre Experience.
    Akkus G; Karagun B; Çetinalp NE; Açıkalın A; Evran M; Sengöz S; Sert M; Zorludemir S; Tetiker T
    Curr Med Imaging; 2021; 17(2):310-317. PubMed ID: 33357196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors, a large single center experience.
    Langlois F; Lim DST; Varlamov E; Yedinak CG; Cetas JS; McCartney S; Dogan A; Fleseriu M
    Endocrine; 2017 Dec; 58(3):528-534. PubMed ID: 29043561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes.
    Cooper O; Ben-Shlomo A; Bonert V; Bannykh S; Mirocha J; Melmed S
    Horm Cancer; 2010 Apr; 1(2):80-92. PubMed ID: 20717480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review.
    Langlois F; Lim DST; Yedinak CG; Cetas I; McCartney S; Cetas J; Dogan A; Fleseriu M
    Pituitary; 2018 Feb; 21(1):32-40. PubMed ID: 29032459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Parameters of Silent Corticotroph Adenomas With Positive and Negative Adrenocorticotropic Hormone Immunostaining: A Large Retrospective Single-Center Study of 105 Cases.
    Zhang K; Shou X; Chen H; Qiao N; He W; Chen Z; Shen M; Li S; Zhao Y; Zhang Z; Li Y; Ye H; Wang Y
    Front Endocrinol (Lausanne); 2020; 11():608691. PubMed ID: 33584540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas.
    Kim D; Ku CR; Park SH; Moon JH; Kim EH; Kim SH; Lee EJ
    World Neurosurg; 2018 Jul; 115():e464-e471. PubMed ID: 29678704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACTH adenomas transforming their clinical expression: report of 5 cases.
    Zoli M; Faustini-Fustini M; Mazzatenta D; Marucci G; De Carlo E; Bacci A; Pasquini E; Lanzino G; Frank G
    Neurosurg Focus; 2015 Feb; 38(2):E15. PubMed ID: 25639317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system.
    Jiang S; Zhu J; Feng M; Yao Y; Deng K; Xing B; Lian W; Wang R; Bao X
    Pituitary; 2021 Aug; 24(4):564-573. PubMed ID: 33651318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of microcystic aspect on T2-weighted MRI for the diagnosis of silent corticotroph adenomas.
    Kasuki L; Antunes X; Coelho MCA; Lamback EB; Galvão S; Silva Camacho AH; Chimelli L; Ventura N; Gadelha MR
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):145-149. PubMed ID: 31773787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plurihormonal pituitary macroadenoma:  a case report.
    Allehaibi E; AlMalki MH; Brema I
    J Med Case Rep; 2021 Jul; 15(1):407. PubMed ID: 34321093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas.
    Mete O; Gomez-Hernandez K; Kucharczyk W; Ridout R; Zadeh G; Gentili F; Ezzat S; Asa SL
    Mod Pathol; 2016 Feb; 29(2):131-42. PubMed ID: 26743473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early recognition of aggressive pituitary adenomas: a single-centre experience.
    Ceccato F; Regazzo D; Barbot M; Denaro L; Emanuelli E; Borsetto D; Rolma G; Alessio L; Gardiman MP; Lombardi G; Albiger N; D'Avella D; Scaroni C
    Acta Neurochir (Wien); 2018 Jan; 160(1):49-55. PubMed ID: 29170844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and outcomes of null-cell versus silent gonadotroph adenomas in a series of 1166 pituitary adenomas from a single institution.
    Haddad AF; Young JS; Oh T; Pereira MP; Joshi RS; Pereira KM; Osorio RC; Donohue KC; Peeran Z; Sudhir S; Jain S; Beniwal A; Chopra AS; Sandhu NS; Theodosopoulos PV; Kunwar S; El-Sayed IH; Gurrola J; Blevins LS; Aghi MK
    Neurosurg Focus; 2020 Jun; 48(6):E13. PubMed ID: 32480370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plurihormonal ACTH-GH Pituitary Adenoma: Case Report and Systematic Literature Review.
    Roca E; Mattogno PP; Porcelli T; Poliani L; Belotti F; Schreiber A; Maffezzoni F; Fontanella MM; Doglietto F
    World Neurosurg; 2018 Jun; 114():e158-e164. PubMed ID: 29501516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, Laboratory, and Treatment Profiles of Silent Corticotroph Adenomas That Have Transformed to the Functional Type: A Case Series With a Literature Review.
    Zheng G; Lu L; Zhu H; You H; Feng M; Liu X; Dai C; Yao Y; Wang R; Zhang H; Sun X; Lu Z
    Front Endocrinol (Lausanne); 2020; 11():558593. PubMed ID: 33071973
    [No Abstract]   [Full Text] [Related]  

  • 16. Silent corticotroph adenomas: Emory University cohort and comparison with ACTH-negative nonfunctioning pituitary adenomas.
    Ioachimescu AG; Eiland L; Chhabra VS; Mastrogianakis GM; Schniederjan MJ; Brat D; Pileggi AV; Oyesiku NM
    Neurosurgery; 2012 Aug; 71(2):296-303; discussion 304. PubMed ID: 22517250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomics model and clinical scale for the preoperative diagnosis of silent corticotroph adenomas.
    Wang H; Chang J; Zhang W; Fang Y; Li S; Fan Y; Jiang S; Yao Y; Deng K; Lu L; Bao X; Feng F; Wang R; Feng M
    J Endocrinol Invest; 2023 Sep; 46(9):1843-1854. PubMed ID: 37020103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas.
    Smith TR; Hulou MM; Huang KT; Nery B; de Moura SM; Cote DJ; Laws ER
    Neurosurg Focus; 2015 Feb; 38(2):E12. PubMed ID: 25639314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
    Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
    World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features of silent corticotroph adenomas.
    Alahmadi H; Lee D; Wilson JR; Hayhurst C; Mete O; Gentili F; Asa SL; Zadeh G
    Acta Neurochir (Wien); 2012 Aug; 154(8):1493-8. PubMed ID: 22619024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.